PEN

Penumbra, Inc.

$321.46

-0.12%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

Source: Yahoo Finance
AI summary

Price & performance

1M+0.2%
3M-0.3%
YTD+3.1%
1Y+37.8%
52-week range—
Beta0.60
Full chart and returns against a benchmark

Q-Score

72/ 100

Quality against peers; 50 is the peer median.

Growth64
Risk79
Performance61
Valuation40
Profitability71
Leverage85
Sentiment21
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.4B+17.5%
Net income$177.7M+1168.1%
Net margin12.7%+11.5 pts
Historical fundamentals

Revenue exposure

22%of revenue from outside the US
United States78%
Non-US22%
Regions, segments, customers and suppliers

Valuation

PENIndustryP/E80.6929.61P/S8.123.49EV/EBITDA59.3018.38P/B8.003.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 4next report
EPS estimate$1.18
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate